Long-term results of choroidal neovascularization secondary to angioid streaks
Graefe's Archive for Clinical and Experimental Ophthalmology Aug 24, 2020
Mori H, et al. - In a long-term follow-up (> 5 years) study, researchers sought to examine factors contributing to the visual prognosis of choroidal neovascularization (CNV) secondary to angioid streaks (AS). Twenty-one patients (32 eyes) affected by CNV secondary to AS were retrospectively recruited and classified into three groups according to the period of CNV recurrence from the final treatment: group A, no recurrence for more than 12 months; group B, no recurrence for 6–12 months; and group C, no recurrence for < 6 months or ongoing. Data reported that the median follow-up time was 91 months. No significant differences were found between initial CRT and final CRT. Due to the presence of peau d'orange areas, choroidal thinning, and increased retinal pigment epithelium atrophy, the visual prognosis was poor despite the regression of CNV secondary to AS following treatment.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries